Search results

• Ketamine
  ...ournal|author=Harrison NL, Simmonds MA |title=Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex |journal=British J ...August | pmid = 19391150 | doi = 10.1002/syn.20647}}</ref> as well as a [[dopamine reuptake inhibitor]].{{Citation needed|date=April 2010}}
  69 KB (9,697 words) - 21:01, 24 September 2010
• Promethazine
  ...eptors without blocking the secretion of histamine. It also is a very weak dopamine antagonist.<ref>David J. McCann and Brett Roth, [http://www.emedicine.com/E [[Category:H1 receptor antagonists]]
  10 KB (1,347 words) - 21:10, 12 September 2010
• Dopamine
  |ImageFile2=Dopamine-3d-CPK.png ...cyclopedia.com/doc/1O87-ventraltegmentalarea.html Reference for VTA.</ref> Dopamine is also a [[neurohormone]] released by the [[hypothalamus]]. Its main funct
  48 KB (6,470 words) - 16:48, 27 September 2010
• Metoclopramide
  ...58:723–7. PMID 14186927.</ref> It appears to bind to [[dopamine receptor|dopamine D₂ receptors]] where it is a [[receptor antagonist]], and is als ...been superseded by the more effective [[5-HT3 antagonist|5-HT₃ antagonists]] (e.g. [[ondansetron]]).
  11 KB (1,453 words) - 16:49, 27 September 2010
• Nitrous oxide
  ...</ref> Indeed, in humans given 30% N₂O, benzodiazepine receptor antagonists reduced the subjective reports of feeling "high", but did not alter psycho- ...O.<ref name="branda"/> Several experiments have shown that opioid receptor antagonists applied directly to the brain block the antinociceptive effects of N<sub>2<
  61 KB (8,728 words) - 16:50, 27 September 2010
• Template:Serotonergics
  ...l]]{{•}} [[Vilazodone]]{{•}} [[Xaliproden]]{{•}} [[Yohimbine]]<br>'''Antagonists''': ''Antipsychotics'': [[Iloperidone]]{{•}} [[Risperidone]]{{•}} [[Se ...129]]{{•}} [[CP-94,253]]{{•}} [[CP-135,807]]{{•}} [[RU-24969]]<br>'''Antagonists''': ''Lysergamides'': [[Metergoline]]; ''Others'': [[AR-A000002]]{{•}} [[
  26 KB (1,619 words) - 22:18, 21 September 2010
• Template:Antidepressants
  ...otonin-norepinephrine-dopamine reuptake inhibitor|Serotonin-norepinephrine-dopamine reuptake inhibitor]]s (SNDRIs)</small> | group5 = <small>[[Dopamine reuptake inhibitor|Dopamine reuptake inhibitor]]s (DRIs)</small>
  13 KB (1,038 words) - 16:53, 27 September 2010
• Template:Cannabinoids
  [[N-Arachidonoyl dopamine]] (NADA){{·w}} | group6 = Cannabinoid receptor <br>antagonists and <br>inverse agonists
  6 KB (590 words) - 20:07, 21 September 2010
• Template:Drugs for functional gastrointestinal disorders
  | list3 = ''[[5-HT3 antagonist|5-HT₃ antagonists]]'' ([[Alosetron]], [[Cilansetron]]){{·}} ''[[Serotonin receptor agonist|5 | list3 = ''[[dopamine antagonist|primarily dopamine antagonists]]'' ([[Metoclopramide]]/[[Bromopride]], [[Clebopride]], [[Domperidone]], [[
  3 KB (224 words) - 12:10, 19 September 2010
• Template:Antiemetics
  | group3 = [[Dopamine antagonist|D₂/D₃ Antagonist]]s
  2 KB (157 words) - 16:53, 27 September 2010
• Template:Adrenergics
  ...Pseudoephedrine]]{{•}} [[Synephrine]]{{•}} [[Tetrahydrozoline]]<br/>'''Antagonists''': [[Abanoquil]]{{•}} [[Adimolol]]{{•}} [[Ajmalicine]]{{•}} [[Alfuzo ...]{{•}} [[Urapidil]]{{•}} [[Xylazine]]{{•}} [[Xylometazoline]]<br/>'''Antagonists''': [[Pyrimidinylpiperazine|1-PP]]{{•}} [[Adimolol]]{{•}} [[Aptazapine]
  19 KB (1,075 words) - 16:53, 27 September 2010
• Template:Antihyperkinetics
  | group8 = [[Dopamine receptor D1|Dopamine D1 receptor]] [[Dopamine D1 receptor#Agonists|agonist]]s
  3 KB (290 words) - 18:34, 19 September 2010
• Template:Hallucinogens
  ...= [[Dissociative]]s<br/>''<small>[[NMDA_receptor|NMDAR]] [[NMDA_antagonist|antagonists]]</small>'' ...br/>''<small>[[Muscarinic_acetylcholine_receptor|mAChR]] [[Anticholinergic|antagonists]]</small>''
  11 KB (1,039 words) - 12:11, 19 September 2010
• Template:Antiaddictives
  ''[[Norepinephrine-dopamine reuptake inhibitor|NDRI]]'' ([[Bupropion]]){{·}} ''[[Adrenergic agonist|AA ...or|mGluR]]'' ([[Acamprosate]]){{·}} ''[[opioid antagonist|Opioid receptor antagonists]]'' ([[Naltrexone]], [[Nalmefene]]){{·}} [[Topiramate]]{{·}} ''[[Adrenerg
  3 KB (233 words) - 12:11, 19 September 2010
• Cannabinoid
  *[[N-arachidonoyl-dopamine]] (NADA) ...known [[monoamine]] [[neurotransmitter]]s, such as [[acetylcholine]] and [[dopamine]], endocannabinoids differ in numerous ways from them. For instance, they u
  49 KB (6,487 words) - 22:06, 21 September 2010
• Tetrahydrocannabinol
  ...tor]] antagonist [[rimonabant]] (SR141716A) as well as [[opioid receptor]] antagonists (opioid blockers) [[naloxone]] and [[naloxonazine]].<ref name="Lupica 2004"
  50 KB (6,686 words) - 22:09, 21 September 2010
• Buprenorphine
  ...] for the [[Mu opioid receptor|μ receptor]] such that [[opioid receptor]] antagonists (e.g. [[naloxone]]) only partially reverse its effects. These two [[chemica ...own to act as an epsilon-opioid antagonist. Several selective agonists and antagonists are now available for the putative epsilon receptor,<ref name="pmid15246090
  59 KB (8,561 words) - 22:13, 21 September 2010
• Phencyclidine
  ...simplications for models of schizophrenia](2002)</ref> Other NMDA receptor antagonists include [[ketamine]], [[tiletamine]], and [[dextromethorphan]]. Although th ...= August | pmid = 19391150 | doi = 10.1002/syn.20647}}</ref> as well as [[dopamine reuptake inhibitor]]s.{{Citation needed|date=April 2010}}
  21 KB (3,002 words) - 21:02, 24 September 2010
• Salvia divinorum
  ...lvinorin A in mice are blocked by κ-Opioid receptor [[receptor antagonist|antagonists]].<ref name="Zhang2005pabs">[[#refZhang2005|Zhang et al. 2005]], p.&nbsp;ab | title = Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide,
  133 KB (18,241 words) - 22:14, 21 September 2010
• Dextromethorphan
  ...agonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries | journal = Journal of Neurosurgical Anesthesio ...ournal |author=Hargreaves R, Hill R, Iversen L |title=Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuro
  26 KB (3,444 words) - 22:15, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)